Bio-Rad Laboratories (BIO) Total Non-Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Total Non-Current Liabilities for 18 consecutive years, with $2.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities changed 0.13% year-over-year to $2.9 billion in Q2 2026; TTM through Jun 2026 was $2.9 billion, a 0.13% change from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 11.7% from the prior year.
• Total Non-Current Liabilities was $2.9 billion for Q2 2026 at Bio-Rad Laboratories, up from $2.7 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $4.0 billion in Q1 2022 and troughed at $2.6 billion in Q4 2024.
• A 5-year average of $3.2 billion and a median of $3.1 billion in 2023 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 29.58% in 2022, down 22.85% in 2022.
• Over 5 years, Total Non-Current Liabilities stood at $3.7 billion in 2022, then fell by 8.88% to $3.4 billion in 2023, then fell by 22.16% to $2.6 billion in 2024, then increased by 11.7% to $2.9 billion in 2025, then dropped by 1.51% to $2.9 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $2.9 billion (Q2 2026), $2.7 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.